SCHEMBL7692146

SCHEMBL7692146

O=C(NCc1ccccc1F)C1CCC(Nc2nc3ccccc3[nH]2)CC1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.55
SMN1; SMN2 Q16637 3/20 0.55
MAPK1 P28482 1/20 0.52
NPC1 O15118 4/20 0.50
RAB9A P51151 3/20 0.50
POLB P06746 3/20 0.50
TDP1 Q9NUW8 1/20 0.50
KDM4E B2RXH2 2/20 0.48
ALDH1A1 P00352 2/20 0.46
RXFP1 Q9HBX9 1/20 0.46
PKM P14618 2/20 0.46
TP53 P04637 1/20 0.45
GAA P10253 1/20 0.45
MAPT P10636 2/20 0.44
MEN1 O00255 1/20 0.44
CASP3 P42574 1/20 0.44
KMT2A Q03164 1/20 0.44
SENP8 Q96LD8 1/20 0.44
SENP7 Q9BQF6 1/20 0.44
SENP6 Q9GZR1 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7692144 1.00 LMNA (0.55) LMNASMN1; SMN2MAPK1NPC1RAB9A
SCHEMBL7698279 0.89 ALDH1A1 (0.56) LMNASMN1; SMN2NPC1RAB9APOLB
SCHEMBL7698276 0.89 ALDH1A1 (0.56) LMNASMN1; SMN2NPC1RAB9APOLB
SCHEMBL7696480 0.88 SMN1; SMN2 (0.55) SMN1; SMN2NPC1RAB9APOLBTDP1
SCHEMBL7696476 0.88 SMN1; SMN2 (0.55) SMN1; SMN2NPC1RAB9APOLBTDP1
SCHEMBL7697358 0.87 EPHX2 (0.58) SMN1; SMN2NPC1RAB9APOLBTDP1
SCHEMBL7692546 0.87 EPHX2 (0.58) SMN1; SMN2NPC1RAB9APOLBTDP1
SCHEMBL7197538 0.87 SMN1; SMN2 (0.54) LMNASMN1; SMN2NPC1RAB9APOLB
SCHEMBL7658865 0.87 SMN1; SMN2 (0.54) LMNASMN1; SMN2NPC1RAB9APOLB
SCHEMBL7693636 0.86 SMN1; SMN2 (0.55) LMNASMN1; SMN2NPC1RAB9APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6291499-B1 TREATING MIGRAINE, DEPRESSION, ANXIETY, SCHIZOPHRENIA, PARKINSON'S DISEASE, OR STROKE MERCK & CO., INC. 2001-09-18 US claimed
US-6380205-B1 QUINAZOLINE THROUGH A C1-C4ALKYL, C1- C4ALKENYL, C1-C4ALKYNYL, C1-C4ALKOXY, AMINO, AMINOC1-C4ALKYL, HYDROXYC1-C4ALKYL, CARBONYL, CYCLOC3-C6ALKYL OR AMINOCARBONYL CHAIN, USEFUL FOR TREATMENT OF THE PAIN MERCK & CO., INC. 2002-04-30 US disclosed
US-6291499-B1 TREATING MIGRAINE, DEPRESSION, ANXIETY, SCHIZOPHRENIA, PARKINSON'S DISEASE, OR STROKE MERCK & CO., INC. 2001-09-18 US disclosed